HNX:MED Revenue

In the year 2025, Mediplantex National Pharmaceutical JSC had annual revenue of 366.83B VND, down -17.22%. Mediplantex National Pharmaceutical JSC had revenue of 117.36B in the quarter ending December 31, 2025, with 10.80% growth.

Revenue

366.83B

Revenue Growth

-17.22%

P/S Ratio

0.69

Revenue / Employee

1.18B

Employees

310

Market Cap

253.16B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	366.83B	-76.31B	-17.22%
Jan 1, 2025	443.14B	40.39B	10.03%
Jan 1, 2024	402.74B	1.69B	0.42%
Dec 31, 2022	401.05B	57.10B	16.60%
Dec 31, 2021	343.95B	-177.44B	-34.03%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Ben Tre Pharmaceutical JSC	860.31B
American Vietnamese Biotech Incorporation	154.07B
Vimedimex Medi-Pharma JSC	812.98B
Phong Phu Pharmaceutical JSC	139.74B
Lamdong Pharmaceutical JSC	243.91B
SPM Corporation	217.45B
Cai Lay Veterinary Pharmaceutical JSC	152.40B
Vidipha Central Pharmaceutical JSC	971.25B

Revenue Rankings